Page last updated: 2024-09-03

n(4)-hexadecyl-1-arabinofuranosylcytosine and cytarabine

n(4)-hexadecyl-1-arabinofuranosylcytosine has been researched along with cytarabine in 8 studies

Compound Research Comparison

Studies
(n(4)-hexadecyl-1-arabinofuranosylcytosine)
Trials
(n(4)-hexadecyl-1-arabinofuranosylcytosine)
Recent Studies (post-2010)
(n(4)-hexadecyl-1-arabinofuranosylcytosine)
Studies
(cytarabine)
Trials
(cytarabine)
Recent Studies (post-2010) (cytarabine)
80015,4872,4243,188

Protein Interaction Comparison

ProteinTaxonomyn(4)-hexadecyl-1-arabinofuranosylcytosine (IC50)cytarabine (IC50)
nuclear receptor coactivator 3 isoform aHomo sapiens (human)7.533
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.02

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, SH; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; Schliselfeld, L; West, CR1
Schott, H; Schwendener, RA2
Horber, DH; Schott, H; Schwendener, RA2
Horber, DH; Schott, H; Schwendener, RA; von Ballmoos, P1
Horber, DH; Odermatt, B; Schott, H; Schwendener, RA1
Hänseler, E; Rentsch, KM; Schott, H; Schwendener, RA1

Other Studies

8 other study(ies) available for n(4)-hexadecyl-1-arabinofuranosylcytosine and cytarabine

ArticleYear
Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:9

    Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytarabine; Drug Resistance; Drug Therapy; Leukemia L1210; Mice; Mice, Inbred DBA; Prodrugs; Stereoisomerism; Structure-Activity Relationship

1988
Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosine.
    International journal of cancer, 1992, May-28, Volume: 51, Issue:3

    Topics: Animals; Cytarabine; Drug Carriers; Drug Screening Assays, Antitumor; Leukemia L1210; Liposomes

1992
Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:6

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cell Differentiation; Cytarabine; Dipyridamole; DNA; Drug Carriers; Drug Interactions; Half-Life; Humans; Leukemia; Liposomes; Tumor Cells, Cultured

1995
Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine.
    British journal of cancer, 1995, Volume: 72, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Cytarabine; DNA Replication; DNA, Neoplasm; Drug Carriers; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Liposomes; S Phase; Tumor Stem Cell Assay

1995
Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
    British journal of cancer, 1995, Volume: 71, Issue:5

    Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cytarabine; Deamination; DNA; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Liposomes; Mice; Microsomes, Liver; Tumor Cells, Cultured

1995
Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine.
    Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:2

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cytarabine; Drug Carriers; Female; Hemolysis; Humans; Leukemia L1210; Liposomes; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Tissue Distribution

1996
Sensitive high-performance liquid chromatographic method for the determination of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabinofuranosylcytosine in plasma and erythrocytes.
    Journal of chromatography. B, Biomedical applications, 1995, Nov-17, Volume: 673, Issue:2

    Topics: Animals; Antineoplastic Agents; Butanols; Chromatography, High Pressure Liquid; Cytarabine; Erythrocytes; Female; Humans; Mice; Mice, Inbred ICR; Reproducibility of Results; Sensitivity and Specificity; Sonication; Urea

1995
Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
    Anti-cancer drug design, 1996, Volume: 11, Issue:6

    Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; Drug Carriers; Female; Leukemia L1210; Liposomes; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Structure; Phospholipids; Prodrugs; Structure-Activity Relationship

1996